Market Overview

UPDATE: Bloom Burton Downgrades YM BioSciences to Hold Post Gilead Acquisition

Share:
Related YMI
YM Biosciences Wins Final Court Order Approving Plan of Arrangement with Gilead
Benzinga's M&A Chatter for Wednesday December 12, 2012

Bloom Burton lowered its rating on YM BioSciences (NYSE: YMI) from Buy to Hold with a $2.95 price target.

Bloom Burton noted, "We are updating our price target to US$2.95 and rating to Hold after last week's announcement of the acquisition of YM by Gilead Sciences (NASDAQ: GILD). … The deal is expected to close in Q1 2013. The deal contains customary non-solicit provisions, but under certain circumstances, YM can terminate the arrangement and accept an unsolicited superior proposal. Considering YM stated it has conducted a robust process for out-licensing the asset, we expect the deal to close with no other bidders coming to the table."

YM BioSciences closed at $2.89 on Friday.

Latest Ratings for YMI

DateFirmActionFromTo
Feb 2013Bloom Burton & Co.TerminatesHold
Jan 2013JMP SecuritiesDowngradesMarket OutperformMarket Perform
Dec 2012PiperJaffrayDowngradesOverweightNeutral

View More Analyst Ratings for YMI
View the Latest Analyst Ratings

Posted-In: Bloom BurtonAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (YMI + GILD)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AAPLWedbushInitiates Coverage On310.0
DHTJP MorganUpgrades0.0
DISBarclaysUpgrades130.0
DXCMGoldman SachsUpgrades125.0
ORLYJP MorganUpgrades398.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Don't Just Go To Jared, Invest In It

UPDATE: KeyBanc Initiates Pool Corporation at Buy on Growth Outlook